Frederick Stehman

  • 7181 Citations
  • 39 h-Index
1978 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Frederick Stehman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Carcinoma Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Cervix Uteri Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Vulva Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1978 1989


Stehman, F. & Ehrlich, C. E.

National Institutes of Health


Project: Research project

patient care
research projects

Publications 1979 2017

  • 7181 Citations
  • 39 h-Index
  • 130 Article
  • 4 Chapter
5 Citations (Scopus)

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

Oliver, K. E., Brady, W. E., Birrer, M., Gershenson, D. M., Fleming, G., Copeland, L. J., Tewari, K., Argenta, P. A., Mannel, R. S., Secord, A. A., Stephan, J. M., Mutch, D. G., Stehman, F., Muggia, F. M., Rose, P. G., Armstrong, D. K., Bookman, M. A., Burger, R. A. & Farley, J. H., 2017, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Disease-Free Survival
71 Citations (Scopus)

Bevacizumab for advanced cervical cancer: Final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Tewari, K. S., Sill, M. W., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H., DiSaia, P. J., Copeland, L. J., Creasman, W. T., Stehman, F., Brady, M. F., Burger, R. A., Thigpen, J. T., Birrer, M. J., Waggoner, S. E., Moore, D. H. & 3 others, Look, K. Y., Koh, W. J. & Monk, B. J., 2017, (Accepted/In press) In : The Lancet.

Research output: Contribution to journalArticle

Uterine Cervical Neoplasms
Drug Therapy
2 Citations (Scopus)

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study

Rose, P. G., Java, J. J., Morgan, M. A., Alvarez-Secord, A., Kesterson, J. P., Stehman, F., Warshal, D. P., Creasman, W. T., Hanjani, P., Morris, R. T. & Copeland, L. J., 2016, In : Gynecologic Oncology. 143, 3, p. 511-515 5 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Disease-Free Survival
Operative Surgical Procedures
Residual Neoplasm
15 Citations (Scopus)

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis

Moore, K. N., Java, J. J., Slaughter, K. N., Rose, P. G., Lanciano, R., DiSilvestro, P. A., Thigpen, J. T., Lee, Y. C., Tewari, K. S., Chino, J., Seward, S. M., Miller, D. S., Salani, R., Moore, D. H. & Stehman, F., Nov 1 2016, In : Gynecologic Oncology. 143, 2, p. 294-301 8 p.

Research output: Contribution to journalArticle

Uterine Cervical Neoplasms
37 Citations (Scopus)
Uterine Cervical Neoplasms
Disease-Free Survival